Skip Maine state header navigation

Agencies | Online Services | Help
||||

 

BIODE

What is Viscosity?

Biosensors Based on Piezoelectric Crystal Detectors

How Quartz Watches Work

Maine Technology Institute

Center for Innovation in Biotechnology

Small Business Innovation Research Gateway

Advanced Technology Program

Report to U.S. EPA on BIODE Project

Environmental Sensor Group at UMaine

Laboratory for Surface Science and Technology

Virostat

 

Westbrook firm senses success

Maine Science and Technology Foundation
October 4, 2002

WESTBROOK, Maine – It's the nature of innovation that a single idea can lead to a multitude of real world applications. BIODE, a Westbrook-based firm, is on a creative roll.

The company was founded to develop a new sensor technology combining solid-phase surface chemistries and ultra-sensitive acoustic devices. Initially, the company's R&D efforts focused exclusively on biochemical detectors. But it became apparent that its sensor technology could be used for detecting other things.

Today BIODE is pursuing an aggressive business plan with a pipeline of products that it expects to perfect and commercialize within the next five years.

Quartz crystals underlie the technology of fluid phase sensors under development at BIODE. The diverse applications for the company's portable sensors range from determining a fluid's viscosity to detecting bioterrorist agents such as anthrax.

The company "is poised for rapid expansion and, upon financing, sees itself in a wide-open playing field with the right team and the right training," says BIODE CEO Michael King.

To the right team and the right training, King might add the right timing; because the federal government's determination to improve the nation's defenses against bioterrorism has created an opportunity for the sensor company to achieve national prominence.

A Viscometer With No Moving Parts

Fulfilling its aggressive business plans will cost money, so BIODE's immediate focus is on equity financing.

"BIODE has been in discussions with venture capitalists and angel investors for the past several months," the company's CEO stated. "BIODE is especially seeking to use equity financing to finish commercialization on its viscometer product line."

The company has developed a unique viscometer that's designed without moving parts. Viscosity measures a fluid's resistance to flow. Typical viscometers employ a spindle that rotates in a cup of liquid and measures the force required to rotate the spindle.

But moving parts in thick fluids can gum up and force frequent cleaning. The BIODE viscometer eliminates this problem and, as an added benefit its design, it "offers the ability to measure directly in the process stream as the working fluid passes by the sensor," according to King, allowing control systems to operate with continuous process information.

BIODE believes it has improved on conventional viscometer design by incorporating quartz crystals into its device. The sensor head of BIODE's viscometer is small – one inch square and a half-inch thick – and can be immersed in a liquid sample as small as 120 ml, in temperatures ranging from 20 to 100 degrees C. The sensor can monitor viscosity and, with proprietary modifications, chemical or biochemical concentrations.

Quartz crystals are key to BIODE's technology platform, which exploits the piezoelectric effect to measure viscosity or detect the presence of a bacterium or virus.

"An oscillating electrical signal will cause the crystal to vibrate," said King, and "the vibration in turn regenerates an electric field." When a material attaches to the surface of a sensor, the oscillation frequency and amplitude are altered.

Will Funds Flow for the Viscometer?

BIODE's In-Process Viscometer has already undergone one round of beta testing. Although BIODE has received around $5 million in funding to research and develop its biosensor and heavy metals sensor detection, the company requires further financing to commercialize the viscometer.

Three state and federal programs have helped the company get to where it is today. BIODE received a Maine Technology Institute development award in 2000, which financed the first pilot production and beta test round. The company has also won grants from the Center for Innovation in Biotechnology and the Small Business Innovation Research (SBIR) program. BIODE will use new funding to conduct further beta testing, implement design changes and prepare for manufacturing.

The volume of inquiries that the company has received about the viscometer tells its CEO that the company is on to something.

Although the viscometer is not yet commercially available, King said that BIODE has received "tremendous market interest, including a potential order for 300 units from the cosmetics industry." Other industries have expressed interest in using it to analyze engine oil, paints, ink, and materials for manufacturing semiconductors and electronics.

King expects "a warm market reception" when BIODE launches the viscometer in 2003 for $3,500. The company aims to eventually sell 1,200 viscometers a year and to extend the product into an analytical instrument for oils and fuels and then to a biosensor system.

Mustering the resources to get to launch is such an important priority that King and BIODE chief technical officer Jeffrey Andle recently brought on a new team member, Kerem Durdag, to lead fundraising efforts. With a background that includes a mechanical engineering degree, business development, work as a chief technical officer, and commercializing several products,

Durdag will also take on chief operating officer responsibilities once the viscometer moves into production. Durdag is pursuing a variety of potential revenue-building partnerships, including licensing technologies or products to other sensor manufacturers or vendors.

Besides searching for equity financing to bring in a quick infusion of cash for the viscometer, BIODE has also submitted proposals for nearly $4 million in grant funding.

As of early September, BIODE had proposals pending with the Maine Technology Institute, the Defense Advanced Research Projects Agency, and several agencies that make awards under the Small Business Innovation Research program.

BIODE also submitted a proposal to the National Institute of Standards and Technology for a $2 million Advanced Technology Program (ATP) grant that would fund two years of research into using sensors to detect bacteria and viruses that cause tropical diseases or can be used as agents of bioterrorism. If BIODE is successful, it will become the first Maine company to win an ATP award.

Next Stops: Engine Oil Analysis and Bioterrorism Sensors

King said BIODE's "most talked about product is undoubtedly the counter bioterrorism system that is in early development." That system uses the same piezoelectric principles behind the viscometer.

"BIODE intends to develop a briefcase-sized instrument to detect trace quantities of up to 20 different bioterrorism agents, such as cholera toxin, botulinum, plague, and anthrax," King said. Detection time for the device is about 30 minutes, and the machine could also be used to detect microbes that cause outbreaks of diseases, such as dengue fever, in developing countries.

BIODE has spent about half of its $5 million of R&D funding finding ways to use biosensor technology for bioterrorism agent detection. If new financing is secured, the company hopes to bring a single-agent detection system to beta testing in late 2003 and the multi-agent system to beta test in 2004. Officials anticipate product launch in 2005.

Bioterrorism may make front-page news, but the next BIODE product to reach the market likely will be an engine oil analysis system. The viscometer has applications in engine oil monitoring and can indicate the need for an oil change. That technology can enable an understanding of how oil ages and predict required maintenance.

Although King believes consumer automotive markets are too cost-sensitive for such a precise piece of machinery, "many applications exist in freight hauling, power generation, and military transportation and warfare platforms, in which potential engine failure is an unacceptable risk." BIODE anticipates beta testing the device in 2003.

BIODE's list of potential new products doesn't end after developing counter-bioterrorism systems. The company plans to extend its product offerings into public health, clinical diagnostics, and building cleanliness to monitor heating, ventilation, and air conditioning. Agriculture is also on the list, targeting food and water safety plus veterinary medicine.

BIODE History and Ties to UMaine

BIODE was founded in 1986 by Douglas McAllister to develop and commercialize a new product for clinical diagnostics. McAllister received a Ph.D. in microbiology from the University of Maine in 1976 and studied the use of biochemically-selective coatings for surfaces. Andle was an electrical engineering graduate student when he began working with McAllister at UMaine in 1988. King is also a UMaine alumnus and holds a degree in electrical engineering.

BIODE currently employs five people and maintains a laboratory space in Westbrook and an accounting office in Bangor. According to King, the company will be seeking a location for manufacturing space, likely in the Portland area.

BIODE projects creating 20 to 40 high-tech Maine jobs in the next several years. And officials suggest that a potential exists for creating a couple hundred assembly jobs if all three products are successful.

 

© 2000-2003 Maine Science & Technology Foundation
Contact: MSTF Or mainescience.org